Robotic-assisted laparoscopic ureterocalicostomy (RALUC): a systematic review of its applications

• by Theodoros Spinos, Panagiotis Kallidonis, Vasileios Tatanis, Kristiana Gkeka, Angelis Peteinaris, Anja Dietel, Ho Thi Phuc, Doreen Trebst, Stefan Siemer, Toni Franz, Evangelos Liatsikos, Jens-Uwe Stolzenburg

• December 17, 2025

A feasibility randomised controlled trial of an exergaming device aimed at improving mobility in children with cerebral palsy

• by Rachel Rapson, Bernie Carter, Harriet Hughes, Jos M. Latour, Wendy Ingram, Jonathan Marsden

• May 3, 2026

Digital Health in Pediatric Neurology: From Episodic to Continuous Care

Digital health has emerged as a transformative force in 21st-century medicine, reshaping the boundaries of healthcare delivery.

• by

• May 12, 2026

• 4 min

Recombinant ADAMTS13: An Enzyme Replacement Therapy for the Management of Congenital Thrombotic Thrombocytopenic Purpura

Congenital thrombotic thrombocytopenic purpura (cTTP) is a rare autosomal recessive condition that causes deficiency of the von Willebrand factor (vWF)-cleaving metalloprotease, ADAMTS13. Recombinant ADAMTS13 (rADAMTS13) is the first FDA-approved product for management of cTTP. This article reviews the pharmacology, pharmacokinetics, efficacy, safety, dosing, administration, and implications for advanced practitioners of rADAMTS13.

• by Taylor P. Robichaux, Kathryn E. Dane, P. Christopher Parish, Justin R. Arnall, Donald C. Moore

• January 9, 2026

• 15 min